Clinical Trials Browser

Phase 1 × pepinemab × Clear all

NCT05378464 2026-01-08

Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer

Phase 1 Recruiting

Breast Neoplasms

NCT03690986 2025-07-23

VX15/2503 in Combination With Ipilimumab or Nivolumab in Patients With Head and Neck Cancer

Phase 1 Recruiting

Squamous Cell Carcinoma of Head and Neck